Sudeep Pharma Limited (NSE:SUDEEPPHRM)

Sudeep Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	267.39	368.07	139.76	103.01	214.74
Short-Term Investments	879.06	150	-	-	-
Trading Asset Securities	-	1.36	1.27	30.33	-
Cash & Short-Term Investments	1,146	519.43	141.03	133.34	214.74
Cash Growth	120.71%	268.32%	5.77%	-37.91%	654176.23%
Accounts Receivable	2,275	1,854	1,446	937.12	1,066
Other Receivables	441.25	313.39	231.64	320.71	111.51
Receivables	2,720	2,170	1,690	1,268	1,185
Inventory	2,160	1,287	665.82	709.97	365.35
Prepaid Expenses	56.47	88.32	18.51	13.73	4.98
Other Current Assets	156.64	176.82	237.86	175.58	191.77
Total Current Assets	6,240	4,241	2,754	2,300	1,962
Property, Plant & Equipment	4,469	2,773	2,246	1,838	1,459
Long-Term Investments	152.68	3.33	3.2	2.05	1.94
Goodwill	682.4	-	-	-	-
Other Intangible Assets	67.53	2.1	3.02	3.95	-
Long-Term Deferred Tax Assets	4.95	3.25	2.28	5.44	4.74
Other Long-Term Assets	132.2	148.43	130.62	51.49	22.88
Total Assets	11,749	7,172	5,139	4,201	3,450

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	684.28	604.8	507.1	384.96	305.54
Accrued Expenses	66.58	47.85	40.71	514.57	578.16
Short-Term Debt	1,019	852.88	548.3	518.17	484.8
Current Portion of Long-Term Debt	121.21	104.13	97.16	104.97	70
Current Portion of Leases	7.98	6.44	7.51	2.86	2.2
Current Income Taxes Payable	9.84	27.88	1.72	20.04	9.66
Other Current Liabilities	110.93	103.59	170.11	162.72	24.83
Total Current Liabilities	2,020	1,748	1,373	1,708	1,475
Long-Term Debt	342.86	395.53	111.43	199.41	282.34
Long-Term Leases	13.37	16.55	22.99	5.42	8.28
Pension & Post-Retirement Benefits	0.39	2.9	3.94	-	2.12
Long-Term Deferred Tax Liabilities	94.03	63.59	58.47	51.33	48.48
Other Long-Term Liabilities	297.58	14.64	9.27	3.83	5.54
Total Liabilities	2,768	2,241	1,579	1,968	1,822

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	112.95	97.23	14.09	14.09	14.09
Additional Paid-In Capital	2,490	-	98.56	98.56	98.56
Retained Earnings	6,287	4,856	3,478	2,150	1,527
Comprehensive Income & Other	-56.76	-21.85	-30.74	-30.08	-11.18
Total Common Equity	8,833	4,931	3,560	2,233	1,628
Minority Interest	147.54	-	-	-	-
Shareholders' Equity	8,981	4,931	3,560	2,233	1,628
Total Liabilities & Equity	11,749	7,172	5,139	4,201	3,450

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	1,504	1,376	787.39	830.83	847.62
Net Cash (Debt)	-357.77	-856.1	-646.37	-697.49	-632.88
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-3.21	-7.89	-5.96	-6.43	-5.83
Filing Date Shares Outstanding	112.95	97.23	31	1.41	1.41
Total Common Shares Outstanding	112.95	97.23	31	1.41	1.41
Working Capital	4,220	2,494	1,381	591.89	486.41
Book Value Per Share	78.21	50.72	114.84	1584.59	1155.38
Tangible Book Value	8,083	4,929	3,557	2,229	1,628
Tangible Book Value Per Share	71.57	50.69	114.74	1581.79	1155.38
Land	133.17	133.17	132.89	131.5	68.48
Buildings	1,188	896.82	840.79	702.97	684.18
Machinery	1,191	875.05	783.77	652.02	467.49
Construction In Progress	1,784	882.17	446.61	259.72	81.27
Leasehold Improvements	30.76	30.76	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 28, 2026

Data Sources Report a data error